{"id":931,"date":"2020-05-14T22:27:43","date_gmt":"2020-05-14T22:27:43","guid":{"rendered":"http:\/\/baltgroup.com\/?post_type=news&#038;p=931"},"modified":"2022-04-06T17:23:11","modified_gmt":"2022-04-06T17:23:11","slug":"balt-receives-ide-approval-from-the-fda-to-begin-the-stem-trial","status":"publish","type":"news","link":"https:\/\/baltgroup.com\/fr\/news\/balt-receives-ide-approval-from-the-fda-to-begin-the-stem-trial\/","title":{"rendered":"Balt re\u00e7oit l'approbation IDE de la FDA pour commencer l'\u00e9tude STEM"},"content":{"rendered":"<p>Balt a annonc\u00e9 aujourd&#039;hui avoir re\u00e7u l&#039;approbation d&#039;exemption pour les dispositifs exp\u00e9rimentaux (IDE) de la Food and Drug Administration (FDA) des \u00c9tats-Unis pour commencer l&#039;essai Squid pour l&#039;embolisation de l&#039;art\u00e8re m\u00e9ning\u00e9e moyenne (STEM) pour le traitement de l&#039;h\u00e9matome sous-dural chronique.<\/p>\n<p><a class=\"btn-lined\" href=\"https:\/\/www.businesswire.com\/news\/home\/20200514005930\/en\/Balt-Receives-IDE-Approval-FDA-STEM-Trial\" target=\"_blank\" rel=\"noopener\">D\u00e9couvrez le communiqu\u00e9 de presse<\/a><\/p>","protected":false},"featured_media":0,"template":"","news_category":[],"class_list":["post-931","news","type-news","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Balt receives IDE approval from the FDA to begin the STEM Trial - Balt Group<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/baltgroup.com\/fr\/news\/balt-receives-ide-approval-from-the-fda-to-begin-the-stem-trial\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Balt receives IDE approval from the FDA to begin the STEM Trial - Balt Group\" \/>\n<meta property=\"og:description\" content=\"Balt announced today it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin The Squid Trial for the Embolization of the Middle meningeal artery (STEM) for the treatment of chronic Sub-Dural Hematoma. Discover the Press Release\" \/>\n<meta property=\"og:url\" content=\"https:\/\/baltgroup.com\/fr\/news\/balt-receives-ide-approval-from-the-fda-to-begin-the-stem-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"Balt Group\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-06T17:23:11+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/baltgroup.com\\\/news\\\/balt-receives-ide-approval-from-the-fda-to-begin-the-stem-trial\\\/\",\"url\":\"https:\\\/\\\/baltgroup.com\\\/news\\\/balt-receives-ide-approval-from-the-fda-to-begin-the-stem-trial\\\/\",\"name\":\"Balt receives IDE approval from the FDA to begin the STEM Trial - Balt Group\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/baltgroup.com\\\/#website\"},\"datePublished\":\"2020-05-14T22:27:43+00:00\",\"dateModified\":\"2022-04-06T17:23:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/baltgroup.com\\\/news\\\/balt-receives-ide-approval-from-the-fda-to-begin-the-stem-trial\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/baltgroup.com\\\/news\\\/balt-receives-ide-approval-from-the-fda-to-begin-the-stem-trial\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/baltgroup.com\\\/news\\\/balt-receives-ide-approval-from-the-fda-to-begin-the-stem-trial\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/baltgroup.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Balt receives IDE approval from the FDA to begin the STEM Trial\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/baltgroup.com\\\/#website\",\"url\":\"https:\\\/\\\/baltgroup.com\\\/\",\"name\":\"Balt Group\",\"description\":\"Inspiring Innovation\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/baltgroup.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Balt re\u00e7oit l&#039;approbation IDE de la FDA pour d\u00e9marrer l&#039;essai STEM - Balt Group","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/baltgroup.com\/fr\/news\/balt-receives-ide-approval-from-the-fda-to-begin-the-stem-trial\/","og_locale":"fr_FR","og_type":"article","og_title":"Balt receives IDE approval from the FDA to begin the STEM Trial - Balt Group","og_description":"Balt announced today it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin The Squid Trial for the Embolization of the Middle meningeal artery (STEM) for the treatment of chronic Sub-Dural Hematoma. Discover the Press Release","og_url":"https:\/\/baltgroup.com\/fr\/news\/balt-receives-ide-approval-from-the-fda-to-begin-the-stem-trial\/","og_site_name":"Balt Group","article_modified_time":"2022-04-06T17:23:11+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/baltgroup.com\/news\/balt-receives-ide-approval-from-the-fda-to-begin-the-stem-trial\/","url":"https:\/\/baltgroup.com\/news\/balt-receives-ide-approval-from-the-fda-to-begin-the-stem-trial\/","name":"Balt re\u00e7oit l&#039;approbation IDE de la FDA pour d\u00e9marrer l&#039;essai STEM - Balt Group","isPartOf":{"@id":"https:\/\/baltgroup.com\/#website"},"datePublished":"2020-05-14T22:27:43+00:00","dateModified":"2022-04-06T17:23:11+00:00","breadcrumb":{"@id":"https:\/\/baltgroup.com\/news\/balt-receives-ide-approval-from-the-fda-to-begin-the-stem-trial\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/baltgroup.com\/news\/balt-receives-ide-approval-from-the-fda-to-begin-the-stem-trial\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/baltgroup.com\/news\/balt-receives-ide-approval-from-the-fda-to-begin-the-stem-trial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/baltgroup.com\/"},{"@type":"ListItem","position":2,"name":"Balt receives IDE approval from the FDA to begin the STEM Trial"}]},{"@type":"WebSite","@id":"https:\/\/baltgroup.com\/#website","url":"https:\/\/baltgroup.com\/","name":"Groupe Balt","description":"Inspirer l&#039;innovation","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/baltgroup.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"ACF":false,"_links":{"self":[{"href":"https:\/\/baltgroup.com\/fr\/wp-json\/wp\/v2\/news\/931","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/baltgroup.com\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/baltgroup.com\/fr\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/baltgroup.com\/fr\/wp-json\/wp\/v2\/media?parent=931"}],"wp:term":[{"taxonomy":"news_category","embeddable":true,"href":"https:\/\/baltgroup.com\/fr\/wp-json\/wp\/v2\/news_category?post=931"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}